Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

ClinicalTrials.gov ID: NCT04442295

Public ClinicalTrials.gov record NCT04442295. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 5:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Investigate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Antisense Oligonucleotide STK-001 in Children and Adolescents With Dravet Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Stoke Therapeutics is evaluating the safety and tolerability of single and multiple ascending doses of STK-001 in patients with Dravet syndrome. Change in seizure frequency, overall clinical status, and quality of life will be measured as secondary endpoints in this open-label study.

Study identification

NCT ID
NCT04442295
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Stoke Therapeutics, Inc
Industry
Enrollment
62 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2020 (Actual)
Primary completion
Nov 14, 2023 (Actual)
Completion
Nov 14, 2023 (Actual)
Last update posted
May 18, 2025

2020 – 2023

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
UCSF Benioff Children's Hospital San Francisco California 94158 —
Children's Hospital Colorado Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nicklaus Children's Hospital Miami Florida 33155 —
AdventHealth Orlando Orlando Florida 32803 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
University of Iowa Hospitals and Clinics; Pediatric Specialty Clinic Iowa City Iowa 52242 —
Massachusetts General Hospital - Pediatric Epilepsy Program Boston Massachusetts 02114 —
University of Michigan - Mott Children's Hospital Ann Arbor Michigan 48109 —
Mayo Clinic Rochester Minnesota 55905 —
NYU Comprehensive Epilepsy Center New York New York 10016 —
Oregon Health & Science University Portland Oregon 97239 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Le Bonheur Children's Hospital Memphis Tennessee 38105 —
Cook Children's Health Care System Fort Worth Texas 76104 —
Primary Children's Hospital Salt Lake City Utah 84108 —
Seattle Children's Hospital Seattle Washington 98105 —
Multicare Institute for Research and Innovation Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04442295, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04442295 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →